Business Standard

Glenmark Pharmaceuticals gets tentative approval for Dronedarone Tablets, 400 mg

Image

Capital Market

From USFDA

Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration for its Dronedarone Tablets, 400 mg, the generic version of Multaq Tablets, 400 mg of Sanofi- Aventis U.S., LLC.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 06 2016 | 10:27 AM IST

Explore News